• gmp-verlag.de
  • GMP MANUAL Login
  • Shopping cart
Stay informed!

You’d like to be regularly informed on the latest developments in Good Manufacturing Practices?

 

Subscribe to our free GMP Newsletter LOGFILE!

>>> REGISTER NOW

The New USP <1231>
Water for Pharmaceutical Purposes

a detailed Overview

>>> ORDER NOW

Award for the
GMP MANUAL

GMP knowledge that convinces.

Image

On 7 June 2016 Maas & Peither GMP Publishing has received a

SIPAward in the category
"Best New Success Story" and was awarded with the 3rd place.

The GMP MANUAL impressed the jury with "Save Drugs through Better GMP Understanding".


GMP MANUAL

GMP in Practice: 24 chapters written by internationally renowned industry experts.

 

GMP Regulations: 8 chapters with the most important GMP guidelines and regulations.

 

Image

>>> READ MORE

TOP 5 GMP Downloads

1. GMP Fundamentals
A quick and comprehensive overview of the complex world of GMP.

 

2. GDP Audit Checklist

More than 700 questions with reference to regulations.

 

3. How to design a Laboratory Data Management System
Practical strategies for designing and implementing an LDMS.


4. Industry Guide to handle OOX Test Results
A concise overview of the OOX process.

 

5. GMP Compliance Basics of Packaging Materials and Processes
Are you on top of the best practices you need to design and create your packaging correctly — every time?

 

>>> More Downloads

News about GMP/cGMP

Anti-Counterfeit (EFPIA)

EFPIA (European Federation of Pharmaceutical Industry and Associations) published the results of their product verification system pilot project on April 12, 2010. The pilot successfully demonstrated a product verification system at the point of drug-dispense of a swedish pharmacy chain. The system is based on a 2-D data matrix code.

 

The pilot project scanned and verified almost 100,000 packs in 25 pharmacies across Stockholm, at the time of dispensing, in collaboration with pharmaceutical retail chain Apoteket AB.  Packs from 14 manufacturers were provided with the 2-D data matrix, allowing each pack to be individually identified. The EFPIA solution could provide a valuable asset in reducing the risk of counterfeit medicines reaching patients via the legitimate supply chain.

Outcome:

To read the complete Final Report, check EFPIAs Website

Links:

EFPIA/ Announcement

EFPIA/ Joint Final Report

Comments
No comment has yet been written about this news.